1 Market Overview
1.1 Product Overview and Scope of 5-in-1 DTaP-Hib-IPV Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 8-month
1.3.3 18-month
1.4 Market Analysis by Application
1.4.1 Overview: Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Community
1.5 Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size & Forecast
1.5.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity (2018-2029)
1.5.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Product and Services
2.1.4 Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
3 Competitive Environment: 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer
3.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer Market Share in 2022
3.5 5-in-1 DTaP-Hib-IPV Vaccine Market: Overall Company Footprint Analysis
3.5.1 5-in-1 DTaP-Hib-IPV Vaccine Market: Region Footprint
3.5.2 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Type Footprint
3.5.3 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Region
4.1.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Region (2018-2029)
4.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.3 Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.5 South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
5.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type (2018-2029)
5.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
6.2 Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application (2018-2029)
6.3 Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
7.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
7.3 North America 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
7.3.1 North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
8.3.1 Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Region
9.3.1 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
10.2 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
10.3 South America 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
10.3.1 South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Market Size by Country
11.3.1 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 5-in-1 DTaP-Hib-IPV Vaccine Market Drivers
12.2 5-in-1 DTaP-Hib-IPV Vaccine Market Restraints
12.3 5-in-1 DTaP-Hib-IPV Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of 5-in-1 DTaP-Hib-IPV Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of 5-in-1 DTaP-Hib-IPV Vaccine
13.3 5-in-1 DTaP-Hib-IPV Vaccine Production Process
13.4 5-in-1 DTaP-Hib-IPV Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 5-in-1 DTaP-Hib-IPV Vaccine Typical Distributors
14.3 5-in-1 DTaP-Hib-IPV Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Major Business
Table 5. Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Product and Services
Table 6. Sanofi Pasteur 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Recent Developments/Updates
Table 8. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 9. Global 5-in-1 DTaP-Hib-IPV Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 10. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 11. Market Position of Manufacturers in 5-in-1 DTaP-Hib-IPV Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 12. Head Office and 5-in-1 DTaP-Hib-IPV Vaccine Production Site of Key Manufacturer
Table 13. 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Type Footprint
Table 14. 5-in-1 DTaP-Hib-IPV Vaccine Market: Company Product Application Footprint
Table 15. 5-in-1 DTaP-Hib-IPV Vaccine New Market Entrants and Barriers to Market Entry
Table 16. 5-in-1 DTaP-Hib-IPV Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 17. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 18. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 19. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 20. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 21. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 22. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 23. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 24. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 25. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 26. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 27. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 28. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 29. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 30. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 31. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 32. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 33. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 34. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 35. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 36. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 37. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 38. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 39. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 40. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 41. North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 42. North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 43. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 46. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 47. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 48. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 49. Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 50. Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 51. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 52. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 53. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 54. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 55. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 56. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 57. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 58. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 59. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 60. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 61. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 62. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 63. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 64. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 65. South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 66. South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 67. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 68. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 69. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 72. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 73. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 74. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 75. 5-in-1 DTaP-Hib-IPV Vaccine Raw Material
Table 76. Key Manufacturers of 5-in-1 DTaP-Hib-IPV Vaccine Raw Materials
Table 77. 5-in-1 DTaP-Hib-IPV Vaccine Typical Distributors
Table 78. 5-in-1 DTaP-Hib-IPV Vaccine Typical Customers
List of Figures
Figure 1. 5-in-1 DTaP-Hib-IPV Vaccine Picture
Figure 2. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Type in 2022
Figure 4. 8-month Examples
Figure 5. 18-month Examples
Figure 6. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Community Examples
Figure 10. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of 5-in-1 DTaP-Hib-IPV Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 5-in-1 DTaP-Hib-IPV Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global 5-in-1 DTaP-Hib-IPV Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa 5-in-1 DTaP-Hib-IPV Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. 5-in-1 DTaP-Hib-IPV Vaccine Market Drivers
Figure 73. 5-in-1 DTaP-Hib-IPV Vaccine Market Restraints
Figure 74. 5-in-1 DTaP-Hib-IPV Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of 5-in-1 DTaP-Hib-IPV Vaccine in 2022
Figure 77. Manufacturing Process Analysis of 5-in-1 DTaP-Hib-IPV Vaccine
Figure 78. 5-in-1 DTaP-Hib-IPV Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
| ※参考情報 5-in-1 DTaP-Hib-IPVワクチンは、小児期における重要な予防接種の一つであり、医療機関によって提供されることで、公衆衛生を推進しています。このワクチンは、5つの病気に対する予防を目的としており、以下の病原体に対する免疫を供与します。 まず、DTaPはジフテリア、破傷風、百日咳に対するワクチンの略称です。ジフテリアは、上気道に感染し、呼吸困難や心筋炎を引き起こす可能性のある重篤な感染症です。破傷風は、土壌に存在する細菌によって引き起こされます。感染すると、筋肉のけいれんや痙攣が生じることがあります。百日咳は、咳が長引く病気で、特に幼児にとって危険です。これらの三つの病気は、公衆衛生の観点から特に重点が置かれており、適切なワクチン接種が推奨されています。 次に、Hibはヘモフィルス・インフルエンザ菌タイプbに対するワクチンを指します。この細菌は、特に2歳以下の幼児に対して、髄膜炎や肺炎、喉頭蓋炎など、深刻な感染症を引き起こす可能性があります。Hibワクチンは、幼児期において重要な役割を果たしています。 そして、IPVは不活化ポリオウイルスワクチンの略です。ポリオは、神経を攻撃するウイルスによって引き起こされる病気で、重度の麻痺を引き起こすことがあります。近年は、世界中でポリオの根絶が目指されており、IPVの導入が重要になっています。 この5-in-1ワクチンの特徴として、1回の接種で5つの病気に対する免疫を獲得できる点が挙げられます。通常、これらのワクチンは個別に接種されることが一般的でしたが、5-in-1ワクチンの登場により、接種回数の減少や医療機関への訪問回数の軽減が実現しました。また、ワクチン接種に伴う痛みや不安が軽減されることで、保護者や子供の負担も軽くなります。 5-in-1 DTaP-Hib-IPVワクチンは、通常生後2ヶ月から接種が始まり、3回の初回接種が推奨されています。この初回接種は、生後2ヶ月、4ヶ月、6ヶ月で行われ、その後4歳から6歳の間に追加接種が行われることが一般的です。これにより、持続的な免疫を確保し、感染症からの保護が提供されます。 5-in-1ワクチンの導入は、感染症の発生率を劇的に低下させる効果を示しています。特に、百日咳やポリオなどの病気は、過去に多くの重篤な状況を引き起こしましたが、ワクチン接種によって新たな感染者を減少させることができました。これにより、集団免疫の観点からも、周囲の人々を守ることに寄与します。 技術的には、5-in-1ワクチンは各病原体に適した不活化または減弱したワクチンを組み合わせて製造されています。これは、抗原が免疫系に認識されることで適切な免疫応答を引き起こすメカニズムに基づいています。また、これまでのワクチン開発において、組み換え技術やアジュバント（免疫反応を強化するための添加物）の使用が進化しており、ワクチンの安全性や効果を高めることに努めています。 最近では、ワクチンに対する理解が高まり、それに伴うワクチン接種率の向上が見られます。公衆衛生機関や医療従事者は、ワクチンの重要性を広めるための教育活動を行っています。正しい情報が提供されることで、接種への抵抗感を軽減し、予防接種に関する誤解を解消することが期待されています。 さらに、ワクチン関連の涼しさに対する懸念もありますが、うまくデータを提供していくことで、多くの人が理解を深め、適切な判断を行うための助けとなります。ワクチンによる副反応については、軽度のものが一般的ですが、重篤な副反応は非常に稀です。医療機関では、接種後の観察を行い、万が一の事態に備えているため、安全性が高いことを確認する体制が整っています。 結論として、5-in-1 DTaP-Hib-IPVワクチンは、幼児期における感染症予防のために不可欠なワクチンであり、その導入により大きな公衆衛生への貢献がなされています。今後も定期的な接種の推進や、ワクチンに関する正確な情報提供が求められるでしょう。これによって、さらに多くの子供たちが感染症から保護され、健康で安全な生活を送ることができるようになることが期待されます。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
